Jawbone CEO quashes rumours over company exiting wearables business

Picture credit: Jawbone

Jawbone CEO Hosain Rahman has said in a blog post that rumours about the company exiting the wearables business are “unequivocally false”.

The post is in response to news last week that the maker of the UP line of fitness trackers had decided to put an end to its business. Rahman said: “To be clear, Jawbone remains wholly committed to innovating in and building great wearables products. We have never been more excited about our pipeline of technology and products and look forward to sharing them with the world when ready.

“We have always managed our inventory positions according to internal business processes and strategic product lifecycle objectives,” he added. “This situation is no different and we will continue to support all of our products.”

Rahman added that the company’s products are very popular and that the wearables innovator is still clocking good sales figures. The post did not offer insight on speculation that Jawbone is working on a “clinical grade” wearable for heart monitoring, though the company has alluded to such a development in the past.

A few months ago, Rahman had revealed that the company plans to use its recent $165 million funding round for a high-grade wearable. The launch of the Apple Watch has heated up competition in the wearables space for Jawbone’s UP range of products.

 

 

https://www.iottechexpo.com/wp-content/uploads/2018/09/iot-tech-expo-world-series.pngInterested in hearing industry leaders discuss subjects like this and sharing their IoT use-cases? Attend the IoT Tech Expo World Series events with upcoming shows in Silicon Valley, London and Amsterdam to learn more.

The show is co-located with the AI & Big Data Expo, Cyber Security & Cloud Expo and Blockchain Expo so you can explore the entire ecosystem in one place.

Leave a comment

Alternatively

This will only be used to quickly provide signup information and will not allow us to post to your account or appear on your timeline.